Published in Cancer Chemother Pharmacol on January 01, 1994
Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis. World J Gastroenterol (2003) 2.07
Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus. World J Gastroenterol (2006) 1.89
Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal vein. World J Gastroenterol (2001) 1.21
Multidisciplinary treatments for hepatocellular carcinoma with major portal vein tumor thrombus. Surg Today (2013) 1.01
Treatment of malignant biliary obstruction by combined percutaneous transhepatic biliary drainage with local tumor treatment. World J Gastroenterol (2006) 1.00
Radiation therapy for portal venous invasion by hepatocellular carcinoma. World J Gastroenterol (2005) 0.89
Treatment of hepatocellular carcinoma with portal vein thrombosis by sorafenib combined with hepatic arterial infusion chemotherapy. Gut Liver (2010) 0.87
Practical effect of sorafenib monotherapy on advanced hepatocellular carcinoma and portal vein tumor thrombosis. Gut Liver (2013) 0.83
Post-radiation survival time in hepatocellular carcinoma based on predictors for CT-determined, transarterial embolization and various other parameters. World J Gastroenterol (2005) 0.80
New Evidence and Perspectives on the Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. J Clin Transl Hepatol (2017) 0.75
PRIMARY LIVER CARCINOMA. AUTOPSY STUDY OF 60 CASES. Cancer (1964) 1.46
Human radiation hepatitis. A morphologic study with emphasis on the late changes. Arch Pathol (1973) 1.20
Quadruple chemotherapy versus radiotherapy in treatment of primary hepatocellular carcinoma. Cancer (1977) 1.06
Hepatic resection for advanced hepatocellular carcinoma with removal of portal vein tumor thrombi. Surgery (1990) 0.96
Radiotherapy in the treatment of hepatocellular carcinoma and its metastases. Cancer Chemother Pharmacol (1992) 0.84
Sonographic evaluation of portal vein thrombosis in hepatocellular carcinoma and liver metastasis. Gaoxiong Yi Xue Ke Xue Za Zhi (1986) 0.75
[Study of 45 patients with hepatocellular carcinoma complicating occlusion of the main portal vein]. Nihon Shokakibyo Gakkai Zasshi (1985) 0.75
Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology (1991) 1.78
The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. A case-control study. Cancer (1992) 1.68
Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma. Cancer (1998) 1.56
Influence of hepatitis C virus on the profiles of patients with chronic hepatitis B virus infection. J Gastroenterol Hepatol (2001) 1.55
Diagnostic value of immunoglobulin G (IgG) and IgM anti-hepatitis E virus (HEV) tests based on HEV RNA in an area where hepatitis E is not endemic. J Clin Microbiol (2000) 1.53
Risk factors for primary lung cancer among non-smoking women in Taiwan. Int J Epidemiol (1997) 1.48
Changes in intrahepatic portal hemodynamic in early stage hepatic abscesses. J Ultrasound Med (1996) 1.38
A case-control study of primary hepatocellular carcinoma in Taiwan. Cancer (1988) 1.35
Influence of neonatal estrogens on rat prostate development. Reprod Fertil Dev (2001) 1.22
Precore mutations and core clustering mutations in chronic hepatitis B virus infection. Gastroenterology (1993) 1.21
Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study. Liver (1994) 1.17
Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan. J Med Virol (1993) 1.14
Independent and additive effect modification of hepatitis C and B viruses infection on the development of chronic hepatitis. J Hepatol (1996) 1.13
Distinct regions of allelic loss on chromosome 4 in human primary bladder carcinoma. Cancer Res (1995) 1.07
Impact of decreased serum transaminase levels on the evaluation of viral hepatitis in hemodialysis patients. Nephron (1995) 1.06
Serum alanine aminotransferase level in relation to hepatitis B and C virus infections among blood donors. Liver (1997) 1.03
Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study. Br J Cancer (1997) 1.02
Duplex pulsed Doppler sonography of portal vein thrombosis in hepatocellular carcinoma. J Ultrasound Med (1991) 1.01
Simultaneous determination of all-trans, 9-cis, 13-cis retinoic acid and retinol in rat prostate using liquid chromatography-mass spectrometry. J Mass Spectrom (2001) 1.00
Virologic factors related to interferon-alpha-induced thyroid dysfunction in patients with chronic hepatitis C. Eur J Endocrinol (2000) 1.00
Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan. Brain Res (1999) 0.99
Changing prevalence of hepatitis C virus genotypes: molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan. J Med Virol (2001) 0.99
Frequency of raised alpha-fetoprotein level among Chinese patients with hepatocellular carcinoma related to hepatitis B and C. Br J Cancer (1994) 0.99
Risk factors for gallstones among Chinese in Taiwan. A community sonographic survey. J Clin Gastroenterol (1990) 0.99
Hepatitis C virus infection among patients with chronic liver disease in an area hyperendemic for hepatitis B. Scand J Gastroenterol (1994) 0.96
Clinical evaluation of the automated COBAS AMPLICOR HCV MONITOR test version 2.0 for quantifying serum hepatitis C virus RNA and comparison to the quantiplex HCV version 2.0 test. J Clin Microbiol (2000) 0.95
Natural killer cell activity in patients with liver cirrhosis relative to severity of liver damage. Dig Dis Sci (1991) 0.93
Developmental exposure to estrogens alters epithelial cell adhesion and gap junction proteins in the adult rat prostate. Endocrinology (2001) 0.93
Effects of hepatitis C and B viruses infection on the development of hepatocellular carcinoma. J Med Virol (1994) 0.93
Circulating immune complexes in chronic hepatitis related to hepatitis C and B viruses infection. Clin Immunol Immunopathol (1995) 0.92
Natural killer cell activity in patients with hepatocellular carcinoma relative to early development and tumor invasion. Cancer (1990) 0.91
Patterns of distant metastases in nasopharyngeal carcinoma. Kaohsiung J Med Sci (1996) 0.90
Role of serum C-reactive protein as a marker of hepatocellular carcinoma in patients with cirrhosis. J Gastroenterol Hepatol (2000) 0.90
Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma. Br J Cancer (1996) 0.90
Complete spontaneous regression of cancer: four case reports, review of literature, and discussion of possible mechanisms involved. Hawaii Med J (2000) 0.89
Different viral aetiology of hepatocellular carcinoma between two hepatitis B and C endemic townships in Taiwan. J Gastroenterol Hepatol (1997) 0.88
Hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Chinese: a case-control study. Int J Cancer (1994) 0.88
Circulating immune complexes in chronic hepatitis C. J Med Virol (1995) 0.87
Clinical application of the Quantiplex HCV RNA 2.0 and Amplicor HCV Monitor assays for quantifying serum hepatitis C virus RNA. J Clin Pathol (1999) 0.87
The effects of traditional antirheumatic herbal medicines on immune response cells. J Rheumatol (1997) 0.87
Clinical evaluation of serum alpha-fetoprotein and circulating immune complexes as tumour markers of hepatocellular carcinoma. Br J Cancer (1995) 0.87
Hepatitis B virus e antigen and primary hepatocellular carcinoma. Anticancer Res (1992) 0.86
Prevalence and manifestations of hepatitis C seropositivity in children in an endemic area. Pediatr Infect Dis J (1998) 0.86
The role of hepatitis C virus in chronic hepatitis B virus infection. Gastroenterol Jpn (1993) 0.85
Relationship of serum alpha-fetoprotein to circulating immune complexes and complements in patients with hepatitis B surface antigen-positive hepatocellular carcinoma. Gastroenterol Jpn (1990) 0.85
Clinical relevance of transforming growth factor-beta 1 in the urine of patients with hepatocellular carcinoma. Medicine (Baltimore) (1997) 0.85
Radiotherapy in the treatment of hepatocellular carcinoma and its metastases. Cancer Chemother Pharmacol (1992) 0.84
External beam radiation therapy for inoperable hepatocellular carcinoma with portal vein thrombosis. Kaohsiung J Med Sci (2001) 0.84
Histopathologic findings and frequency of clonality detected by the polymerase chain reaction in ocular adnexal lymphoproliferative lesions. Mod Pathol (1996) 0.84
GB virus C/hepatitis G virus infection in chronic hepatitis C patients with and without interferon-alpha therapy. Antiviral Res (2001) 0.83
Increased IgM-containing circulating immune complexes in patients co-infected with hepatitis C and hepatitis B. Medicine (Baltimore) (1995) 0.83
Hepatic focal nodular hyperplasia: findings on color Doppler ultrasound. Abdom Imaging (1997) 0.83
Urinary transforming growth factor beta1 levels in hepatitis C virus-related chronic liver disease: correlation between high levels and severity of disease. Hepatology (1997) 0.82
Elevation of circulating immune complexes and its relationship to alpha-fetoprotein levels in patients with hepatitis B surface antigen-positive hepatocellular carcinoma. Cancer Invest (1991) 0.82
Incidence of hepatitis C infection in a hepatitis C endemic township in southern Taiwan. Kaohsiung J Med Sci (1997) 0.82
Sequential changes of serum transaminase and abdominal sonography in patients with suspected dengue fever. Gaoxiong Yi Xue Ke Xue Za Zhi (1990) 0.82
Paraumbilical vein tumor thrombosis in hepatocellular carcinoma. Am J Gastroenterol (1994) 0.82
Development of portal vein invasion and its outcome in hepatocellular carcinoma treated by transcatheter arterial chemo-embolization. J Gastroenterol Hepatol (1994) 0.81
Clinical evaluation of urinary transforming growth factor-beta1 and serum alpha-fetoprotein as tumour markers of hepatocellular carcinoma. Br J Cancer (1997) 0.81
The genotypes of hepatitis C virus in patients with chronic hepatitis C virus infection in southern Taiwan. Kaohsiung J Med Sci (1996) 0.81
Elevated urinary transforming growth factor-beta1 level as a tumour marker and predictor of poor survival in cirrhotic hepatocellular carcinoma. Br J Cancer (1997) 0.81
Ureteral obstruction associated with prostate cancer: the outcome after percutaneous nephrostomy. J Urol (1990) 0.81
Post-traumatic intracranial meningioma. A case report. Taiwan Yi Xue Hui Za Zhi (1972) 0.80
Critical components of the pluripotency network are targets for the p300/CBP interacting protein (p/CIP) in embryonic stem cells. Stem Cells (2014) 0.80
Immunoglobulin- and hepatitis B surface antigen-specific circulating immune complexes in chronic hepatitis B virus infection. Clin Immunol Immunopathol (1998) 0.80
The effects of radiation therapy on salivary function in patients with head and neck cancer. Gaoxiong Yi Xue Ke Xue Za Zhi (1993) 0.80
Abdominal sonographic screening in a single community. Gaoxiong Yi Xue Ke Xue Za Zhi (1990) 0.79
Hepatitis B surface antigen- and immunoglobulin-specific circulating immune complexes in acute hepatitis B virus infection. Clin Immunol Immunopathol (1996) 0.79
Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization and analysis of prognostic factors. Cancer Chemother Pharmacol (1992) 0.79
Serotyping and genotyping of hepatitis C virus in Taiwanese patients with type C chronic liver disease and uraemic patients on maintenance haemodialysis. J Gastroenterol Hepatol (2000) 0.79
Hepatitis delta virus superinfection among patients with chronic hepatitis B in southern Taiwan. Scand J Infect Dis (1990) 0.79
Multiple inflammatory pseudotumors of the spleen: case report. Abdom Imaging (2003) 0.78
Treatment of hepatocellular carcinoma smaller than 5 cm by transcatheter arterial chemoembolization. Kaohsiung J Med Sci (1996) 0.78
Fertility issues in the therapy of nonseminomatous testicular tumors. Urol Clin North Am (1987) 0.78
The molecular epidemiology and clinical significance of TT virus (TTV) infection in healthy blood donors from southern Taiwan. Transfus Apher Sci (2001) 0.78
Status and natural course of GB virus C/hepatitis G virus infection among high-risk groups and volunteer blood donors in Taiwan. J Gastroenterol Hepatol (2000) 0.78
Comparison of necrotic characteristics and benefits between 50% acetic acid and pure ethanol in local hepatic injection: a study in rats. Kaohsiung J Med Sci (1999) 0.78
The serological and molecular epidemiology of GB virus C/hepatitis G virus infection in a hepatitis C and B endemic area. J Infect (2001) 0.78
Factor analysis for the presence of serum HBV DNA in chronic hepatitis B virus infection. Taiwan Yi Xue Hui Za Zhi (1989) 0.78
Voxel-based texture mapping for medical data. Comput Med Imaging Graph (2002) 0.78
Recovery of the hematopoietic system by Si-Jun-Zi-Tang in whole body irradiated mice. J Ethnopharmacol (1996) 0.78
The prevalence of TT virus and GB virus C/hepatitis G virus infection in individuals with raised liver enzymes but without HBV or HCV infection in Taiwan. Epidemiol Infect (2002) 0.78
Inhibition of human prostate cancer cells growth by gossypol is associated with stimulation of transforming growth factor-beta. Cancer Lett (1996) 0.78
Prevalence and size of simple hepatic cysts in Taiwan: community- and hospital-based sonographic surveys. Gaoxiong Yi Xue Ke Xue Za Zhi (1995) 0.78
Doppler sonography of common hepatic duct tumor invasion in hepatocellular carcinoma: report of two cases. J Ultrasound Med (1995) 0.77
Gossypol arrests human benign prostatic hyperplastic cell growth at G0/G1 phase of the cell cycle. Anticancer Res (1997) 0.77
Urinary transforming growth factor-beta 1 in relation to serum alpha-fetoprotein in hepatocellular carcinoma. Scand J Gastroenterol (1997) 0.77
Clinical utility of pulsed Doppler in the detection of arterioportal shunting in patients with hepatocellular carcinoma. J Ultrasound Med (1992) 0.77
Plasma isocitrate dehydrogenase as a marker of centrilobular hepatic necrosis in patients with hyperthyroidism. J Clin Gastroenterol (2001) 0.77
Regulation of arginase production by glucocorticoid in three human gastric cancer cell lines. Life Sci (1992) 0.77
Treatment of chronic hepatitis C with interferon-alpha: a preliminary report. Kaohsiung J Med Sci (1996) 0.77
Aqueous acupuncture for postoperative pain--a matched controlled trial. Gaoxiong Yi Xue Ke Xue Za Zhi (1991) 0.77
Incidence and associated factors of neutralizing anti-interferon antibodies among chronic hepatitis C patients treated with interferon in Taiwan. Scand J Gastroenterol (2000) 0.77
Alpha-fetoprotein in patients with hepatocellular carcinoma after transcatheter arterial embolization. J Gastroenterol Hepatol (1993) 0.76
Changes of serum copper and zinc levels in patients with nasopharyngeal carcinoma by radiotherapy. Biol Trace Elem Res (1995) 0.76
Hepatitis C virus infection among teenagers in an endemic township in Taiwan: epidemiological and clinical follow-up studies. Epidemiol Infect (2001) 0.76
Radioprotective effect of Ganoderma lucidum (Leyss. ex. Fr.) Karst after X-ray irradiation in mice. Am J Chin Med (1990) 0.76
Sonographic evaluation of portal vein thrombosis in hepatocellular carcinoma and liver metastasis. Gaoxiong Yi Xue Ke Xue Za Zhi (1986) 0.75